Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Adelman

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
North Carolina Medical Journal|July 1, 1991
Analgesic induced headacheJ U Adelman
Headache|June 12, 2001
Headaches and papilledema secondary to dural arteriovenous malformationJ U Adelman
Headache|July 1, 1995
Possible increased risk of myocardial infarction from calcium-channel blocking medicationsJ U Adelman, R von Seggern
Clinical Therapeutics|July 7, 2001
Current options for the prevention and treatment of migraineJ U Adelman, R D Adelman
The American Journal of Managed Care|March 8, 1998
Cost of migraine management: a pharmacoeconomic overviewA M Rapoport, J U Adelman
Headache|September 1, 1995
Cost considerations in headache treatment. Part 1: Prophylactic migraine treatmentJ U Adelman, R Von Seggern
Clinical Cornerstone|May 13, 2003
Comparative aspects of triptans in treating migraineJ U Adelman, E J Lewit
North Carolina Medical Journal|June 1, 1995
Office Rx. A renewed professional relationshipJ U Adelman, R L Von Seggern
Headache|June 1, 1997
Oral narcotic protocol to reduce narcotic injections in refractory migraine patientsR L Von Seggern, J U Adelman
Headache|September 1, 1996
Cost considerations in headache treatment. Part 2: Acute migraine treatmentR L Von Seggern, J U Adelman
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
North Carolina Medical Journal|July 1, 1991
Analgesic induced headacheJ U Adelman
Headache|June 12, 2001
Headaches and papilledema secondary to dural arteriovenous malformationJ U Adelman
Headache|July 1, 1995
Possible increased risk of myocardial infarction from calcium-channel blocking medicationsJ U Adelman, R von Seggern
Clinical Therapeutics|July 7, 2001
Current options for the prevention and treatment of migraineJ U Adelman, R D Adelman
The American Journal of Managed Care|March 8, 1998
Cost of migraine management: a pharmacoeconomic overviewA M Rapoport, J U Adelman
Headache|September 1, 1995
Cost considerations in headache treatment. Part 1: Prophylactic migraine treatmentJ U Adelman, R Von Seggern
Clinical Cornerstone|May 13, 2003
Comparative aspects of triptans in treating migraineJ U Adelman, E J Lewit
North Carolina Medical Journal|June 1, 1995
Office Rx. A renewed professional relationshipJ U Adelman, R L Von Seggern
Headache|June 1, 1997
Oral narcotic protocol to reduce narcotic injections in refractory migraine patientsR L Von Seggern, J U Adelman
Headache|September 1, 1996
Cost considerations in headache treatment. Part 2: Acute migraine treatmentR L Von Seggern, J U Adelman
Pageof 2